Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Osteoporosis Drugs Linked to Heart Problems

Ivanhoe Newswire


Related Encyclopedia
 border=
Alzheimer's Disease
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Coming Around: Coma Breakthroughs
Baby Steps: Fertility Findings
Saving Memories with a Shake: The Alzheimer's Drink
Suffocating Damaged Nerves Back to Life
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
More...

Related Drug Information
 border=
Actonel
Cialis
Coumadin
Detrol LA
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
Young Women Who Drink and Drive at Higher Risk of Fatal Accident
Bacteria From Mouth Can Lead to Heart Inflammation: Study
More...

(Ivanhoe Newswire) -- The millions of Americans who take drugs commonly prescribed to treat osteoporosis could be at risk for irregular heartbeats, which could lead to hospitalization or even death, according to a new study.

Researchers found people who take bisphosphonates, which include alendronate or zoledronic acid, for osteoporosis or low bone density were significantly more likely to experience serious atrial fibrillation (AF) compared with those who took a placebo.

Text Continues Below



Jennifer Miranda, M.D., of Jackson Memorial Hospital in Miami and colleagues from the University of Miami evaluated the link between bisphosphonates and AF, a condition that can produce a wide variety of symptoms, including light-headedness, palpitations, chest pain and shortness of breath. They examined the records of 16,322 patients, of whom 76 to 100 percent were women taking bisphosphonates for osteoporosis with a mean age range of 69 to 75 years.

The scientists discovered 2.5 to 3 percent of patients taking bisphosphonates experienced AF and 1 to 2 percent experienced serious AF, including hospitalization and death. Patients taking bisphosphonates were more likely to experience AF and up to two times more likely to experience serious AF than patients taking placebos.

In patients with increased risk factors for atrial fibrillation, clinicians should be more cautious when choosing treatment for osteoporosis and weigh the risks against the benefit of decreased fracture risk, Miranda said.

SOURCE: Study presented at the 74th annual international scientific assembly of the American College of Chest Physicians held October 25-30 in Philadelphia, Pa.

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Lindsay Braun at lbraun@ivanhoe.com.

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 10/28/2008

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire